
BNTX Valuation
Biontech SE
- Overview
- Forecast
- Valuation
- Earnings
BNTX Relative Valuation
BNTX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BNTX is overvalued; if below, it's undervalued.
Historical Valuation
Biontech SE (BNTX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 9.83 is considered Undervalued compared with the five-year average of -3.70. The fair price of Biontech SE (BNTX) is between 1066.29 to 1116.09 according to relative valuation methord. Compared to the current price of 114.57 USD , Biontech SE is Undervalued By 89.26%.
Relative Value
Fair Zone
1066.29-1116.09
Current Price:114.57
89.26%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.23
P/B
Median3y
1.33
Median5y
5.47
-2.22
FCF Yield
Median3y
22.14
Median5y
14.24
Competitors Valuation Multiple
The average P/S ratio for BNTX's competitors is 387.44, providing a benchmark for relative valuation. Biontech SE Corp (BNTX) exhibits a P/S ratio of 9.83, which is -97.46% above the industry average. Given its robust revenue growth of -2.56%, this premium appears unsustainable.
People Also Watch

CHD
Church & Dwight Co Inc
96.400
USD
-0.90%

ITUB
Itau Unibanco Holding SA
6.370
USD
+0.31%

HAL
Halliburton Co
22.240
USD
-0.80%

IOT
Samsara Inc
38.560
USD
+1.15%

WPM
Wheaton Precious Metals Corp
92.910
USD
-1.17%

LPLA
LPL Financial Holdings Inc
380.780
USD
+1.06%

DOV
Dover Corp
185.010
USD
-0.87%

SYF
Synchrony Financial
72.640
USD
+1.16%

EQR
Equity Residential
67.340
USD
-0.46%

CPAY
Corpay Inc
331.970
USD
-0.47%
FAQ

Is Biontech SE (BNTX) currently overvalued or undervalued?
Biontech SE (BNTX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 9.83 is considered Undervalued compared with the five-year average of -3.70. The fair price of Biontech SE (BNTX) is between 1066.29 to 1116.09 according to relative valuation methord. Compared to the current price of 114.57 USD , Biontech SE is Undervalued By 89.26% .

What is Biontech SE (BNTX) fair value?

How does BNTX's valuation metrics compare to the industry average?

What is the current P/B ratio for Biontech SE (BNTX) as of Jul 25 2025?

What is the current FCF Yield for Biontech SE (BNTX) as of Jul 25 2025?

What is the current Forward P/E ratio for Biontech SE (BNTX) as of Jul 25 2025?
